Overexpression of ezrin contributes to the progression and invasiveness of several human cancers; however, its role in breast cancer metastasis has not been investigated in detail.
Methods
Ezrin expression in tissue samples from patients with invasive ductal carcinoma of the breast was detected by immunohistochemistry. Ezrin expression in a breast cancer cell line was evaluated using Western blot and RT-PCR.
Results
Elevated expression of ezrin was associated with lymph node metastasis and poor prognosis in patients with invasive ductal carcinoma. Ezrin expression was related to the invasiveness of breast cancer cells in vitro. Low-dose epirubicin inhibited the migration of breast cancer cells in a concentration-dependent manner without promoting cytotoxicity in vitro and decreased the expression of ezrin in a concentration-dependent manner.
Conclusions
Low-dose epirubicin may be antimetastatic without promoting cytotoxic effects and could serve as a target for the development of therapeutics for breast carcinoma.
ChengL., ItohK., LemmonV.: L1-mediated branching is regulated by two ezrin-radixin-moesin (ERM)-binding sites, the RSLE region and a novel juxtamembrane ERM-binding region.J Neurosci, 25: 395–403, 2005.
HeiskaL., CarpénO.: Src phosphorylates ezrin at tyrosine 477 and induces a phosphospecific association between ezrin and a kelch-repeat protein family member.J Biol Chem, 280: 10244–10252, 2005.
4.
SwansonK.A., CraneD.D., CaldwellH.D.: Chlamydia trachomatis species-specific induction of ezrin tyrosine phosphorylation functions in pathogen entry.Infect Immun, 75: 5669–5677, 2007.
5.
IlaniT., KhannaC., ZhouM., VeenstraT.D., BretscherA.: Immune synapse formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin.J Cell Biol, 179: 733–746, 2007.
6.
StapletonG., MalliriA., OzanneB.W.: Downregulated AP-1 activity is associated with inhibition of protein-kinase-c-dependent CD44 and ezrin localisation and upregulation of PKC theta in A431 cells.J Cell Sci, 115: 2713–2724, 2002.
7.
BarreiroO., Yáñez-MóM., SerradorG.M., MontoyaM.C., Vicente-ManzanaresM., TejedorR., FurthmayrH., Sanchez-MadridF.: Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes.J Cell Biol, 157: 1233–1245, 2002.
8.
OhtaniK., SakamotoH., RutherfordT., ChenZ., KikuchiA., YamamotoT., SatohK., NaftolinF.: Ezrin, a membrane-cytoskeletal linking protein, is highly expressed in atypical endometrial hyperplasia and uterine endometrioid adenocarcinoma.Cancer Lett, 179: 79–86, 2002.
9.
ChenZ., FadielA., FengY., OhtaniK., RutherfordT., NaftolinF.: Ovarian epithelial carcinoma tyrosine phosphorylation, cell proliferation, and ezrin translocation are stimulated by interleukin 1alpha and epidermal growth factor.Cancer, 92: 3068–3075, 2001.
